Jason Grebely
Impact in
- Hepatology top 0.02%
- Hepatitis C virus research
- Epidemiology top 0.1%
- Hepatitis B Virus Studies
- HIV, Drug Use, Sexual Risk
- Liver Disease Diagnosis and Treatment
- Substance Abuse Treatment and Outcomes
Papers in
- Hepatology 285
- Hepatitis C virus research 285
- Epidemiology 148
- Hepatitis B Virus Studies 90
- Liver Disease Diagnosis and Treatment 70
- HIV, Drug Use, Sexual Risk 55
- Co-authors
- Gregory J. Dore (226 shared papers)Behzad Hajarizadeh (91 shared papers)Matthew Hickman (45 shared papers)Louisa Degenhardt (61 shared papers)Sarah Larney (31 shared papers)Peter Vickerman (44 shared papers)Evan B. Cunningham (53 shared papers)Margaret Hellard (65 shared papers)
- Journals
- International Journal of Drug Policy (58 papers)Journal of Hepatology (50 papers)Journal of Viral Hepatitis (30 papers)Clinical Infectious Diseases (18 papers)Drug and Alcohol Dependence (16 papers)
- Partner nations
- AustraliaCanadaUnited Kingdom
In The Last Decade
Jason Grebely
345 papers receiving 14.9k citations
Jason Grebely's Hit Papers
Peers
Comparison fields: 5 of 156
- Hepatology 9.6k
- Epidemiology 6.7k
- Infectious Diseases 1.3k
- Virology 291
- Public Health, Environmental and Occupational Health 1.2k
Countries citing papers authored by Jason Grebely
This map shows the geographic impact of Jason Grebely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Grebely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Grebely more than expected).
Fields of papers citing papers by Jason Grebely
This network shows the impact of papers produced by Jason Grebely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Grebely. The network helps show where Jason Grebely may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason Grebely, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 362 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review Hit paper breakdown → | 2017 | 1024 |
| 2 | Epidemiology and natural history of HCV infection Hit paper breakdown → | 2013 | 762 |
| 3 | Global statistics on alcohol, tobacco and illicit drug use: 2017 status report Hit paper breakdown → | 2018 | 717 |
| 4 | Global patterns of opioid use and dependence: harms to populations, interventions, and future action Hit paper breakdown → | 2019 | 517 |
| 5 | Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals Hit paper breakdown → | 2013 | 368 |
| 6 | Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression Hit paper breakdown → | 2017 | 349 |
| 7 | Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence Hit paper breakdown → | 2021 | 345 |
| 8 | Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States Hit paper breakdown → | 2015 | 329 |
| 9 | Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review Hit paper breakdown → | 2017 | 297 |
| 10 | 2013 | 241 | |
| 11 | 2018 | 177 | |
| 12 | 2012 | 176 | |
| 13 | 2018 | 167 | |
| 14 | 2007 | 166 | |
| 15 | 2019 | 159 | |
| 16 | 2017 | 151 | |
| 17 | 2009 | 147 | |
| 18 | 2013 | 147 | |
| 19 | 2010 | 138 | |
| 20 | 2015 | 137 |
About Jason Grebely
Jason Grebely is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health and Virology, having authored 362 papers that have together received 15.2k indexed citations. Recurring topics across this work include Hepatitis C virus research (285 papers), Hepatitis B Virus Studies (90 papers), Liver Disease Diagnosis and Treatment (70 papers), HIV, Drug Use, Sexual Risk (55 papers), HIV/AIDS drug development and treatment (21 papers), Opioid Use Disorder Treatment (16 papers), HIV Research and Treatment (12 papers) and HIV/AIDS Research and Interventions (6 papers). The work is most often cited by research in Hepatology (9.6k citations), Epidemiology (6.7k citations), Infectious Diseases (1.3k citations), Virology (291 citations) and Public Health, Environmental and Occupational Health (1.2k citations). Jason Grebely has collaborated with scholars based in Australia, Canada and United Kingdom. Frequent co-authors include Gregory J. Dore, Behzad Hajarizadeh, Matthew Hickman, Louisa Degenhardt, Sarah Larney, Peter Vickerman, Evan B. Cunningham, Margaret Hellard, Amy Peacock and Andrew R. Lloyd. Their work appears in journals such as International Journal of Drug Policy, Journal of Hepatology, Journal of Viral Hepatitis, Clinical Infectious Diseases and Drug and Alcohol Dependence.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.